BioCentury
ARTICLE | Clinical News

AVI BioPharma preclinical data

November 2, 2009 8:00 AM UTC

In a mouse model of DMD, a mouse formulation of AVI-5038 targeting the mouse homolog of exon 50 of the human dystrophin gene resulted in almost complete skipping of the targeted exon in muscle tissue...